Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/29134
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWhiteley, Daviden_UK
dc.contributor.authorWhittaker, Anneen_UK
dc.contributor.authorElliott, Lawrieen_UK
dc.contributor.authorCunningham-Burley, Sarahen_UK
dc.date.accessioned2019-03-29T01:01:17Z-
dc.date.available2019-03-29T01:01:17Z-
dc.date.issued2016-12en_UK
dc.identifier.urihttp://hdl.handle.net/1893/29134-
dc.description.abstractBackground International discourse concerning the evolution in hepatitis C virus (HCV) therapy has tended to focus on improving outcomes, shortened treatment length and reduced side-effects of interferon-free regimens. How these treatments are being understood and experienced by the people receiving them has so far been overlooked. This study therefore aimed to explore the lived experience of individuals taking interferon-free HCV therapies. Methods Data were generated through 16 semi-structured interviews with a purposive sample of eight participants, recruited from a university hospital in Scotland. The interviews took place between June 2015 and March 2016, before and after a period of interferon-free HCV treatment. The data were interrogated using a thematic analysis, underpinned by social phenomenological theory. Results Three overriding themes were identified. ‘Expectations and realisations’ characterised the influence that interferon continued to cast over interferon-free treatment, contrasting the practicalities of taking interferon-free therapy with preconceived notions. ‘An honour and a pleasure’ portrayed a positive experience of an undemanding therapy, yet among those with a history of drug use, was also positioned as a privilege, associated with feelings of luck and guilt. ‘Treatment needs’ illustrated the strategies participants used to search for treatment efficacy, and the value those with a significant history of drug use placed on support. One nonconforming case is then discussed to enhance rigour and trustworthiness. Conclusion This is the first qualitative exploration of the experience of interferon-free HCV treatment reported globally. The results from this study suggest a cultural lag exists between the pharmacological developments which have been witnessed, and societal understandings of them. This has implications for the way services meet the needs of, and offer therapy to, HCV positive individuals.en_UK
dc.language.isoenen_UK
dc.publisherElsevier BVen_UK
dc.relationWhiteley D, Whittaker A, Elliott L & Cunningham-Burley S (2016) The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy, 38, pp. 21-28. https://doi.org/10.1016/j.drugpo.2016.10.013en_UK
dc.rightsAccepted refereed manuscript of: Whiteley D, Whittaker A, Elliott L & Cunningham-Burley S (2016) The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy, 38, pp. 21-28. DOI: https://doi.org/10.1016/j.drugpo.2016.10.013 © 2016, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/en_UK
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_UK
dc.subjectAntiviral agentsen_UK
dc.subjectHepatitis Cen_UK
dc.subjectInterferon-freeen_UK
dc.subjectLived experienceen_UK
dc.subjectQualitative researchen_UK
dc.subjectTherapeuticsen_UK
dc.titleThe lived experience of interferon-free treatments for hepatitis C: A thematic analysisen_UK
dc.typeJournal Articleen_UK
dc.identifier.doi10.1016/j.drugpo.2016.10.013en_UK
dc.identifier.pmid27842250en_UK
dc.citation.jtitleInternational Journal of Drug Policyen_UK
dc.citation.issn0955-3959en_UK
dc.citation.volume38en_UK
dc.citation.spage21en_UK
dc.citation.epage28en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusAM - Accepted Manuscripten_UK
dc.contributor.funderClinical Academic Research Career (CARC) Schemeen_UK
dc.citation.date11/11/2016en_UK
dc.contributor.affiliationEdinburgh Napier Universityen_UK
dc.contributor.affiliationEdinburgh Napier Universityen_UK
dc.contributor.affiliationGlasgow Caledonian Universityen_UK
dc.contributor.affiliationUniversity of Edinburghen_UK
dc.identifier.isiWOS:000390745600005en_UK
dc.identifier.scopusid2-s2.0-84995387893en_UK
dc.identifier.wtid1035282en_UK
dc.contributor.orcid0000-0001-8960-5070en_UK
dc.date.accepted2016-10-19en_UK
dcterms.dateAccepted2016-10-19en_UK
dc.date.filedepositdate2019-03-28en_UK
rioxxterms.apcnot requireden_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionAMen_UK
local.rioxx.authorWhiteley, David|en_UK
local.rioxx.authorWhittaker, Anne|0000-0001-8960-5070en_UK
local.rioxx.authorElliott, Lawrie|en_UK
local.rioxx.authorCunningham-Burley, Sarah|en_UK
local.rioxx.projectProject ID unknown|Clinical Academic Research Career (CARC) Scheme|en_UK
local.rioxx.freetoreaddate2019-03-28en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by-nc-nd/4.0/|2019-03-28|en_UK
local.rioxx.filenameThe_lived_experience_of_interferon_free_treatments_for_hepatitis_C_a_thematic_analysis.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source0955-3959en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
The_lived_experience_of_interferon_free_treatments_for_hepatitis_C_a_thematic_analysis.pdfFulltext - Accepted Version502.91 kBAdobe PDFView/Open


This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.